Johnson & Johnson vs. Nuvation Bio Inc.
Johnson & Johnson and Nuvation Bio Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | NUVB | |
|---|---|---|
| Market Cap | $664.95 billion | $1.47 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | NUVB | |
|---|---|---|
| Dividend Yield | 1.94% | — |
JNJ and NUVB split the dividend factors evenly.
Risk & Sentiment
| JNJ | NUVB | |
|---|---|---|
| Short Interest | 0.67% | 0.00% |
NUVB leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, NUVB overview, NUVB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.